These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Aripiprazole in pervasive developmental disorder not otherwise specified and Asperger's disorder: a 14-week, prospective, open-label study. Stigler KA; Diener JT; Kohn AE; Li L; Erickson CA; Posey DJ; McDougle CJ J Child Adolesc Psychopharmacol; 2009 Jun; 19(3):265-74. PubMed ID: 19519261 [TBL] [Abstract][Full Text] [Related]
7. Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders. McDougle CJ; Stigler KA; Erickson CA; Posey DJ J Clin Psychiatry; 2008; 69 Suppl 4():15-20. PubMed ID: 18533764 [TBL] [Abstract][Full Text] [Related]
8. Aripiprazole improves social interaction in Taiwanese children with pervasive developmental disorder. Huang SC; Tsai SJ; Yang HJ Chang Gung Med J; 2010; 33(2):211-5. PubMed ID: 20438675 [TBL] [Abstract][Full Text] [Related]
9. Aripiprazole for the treatment of irritability associated with autism. Farmer CA; Aman MG Expert Opin Pharmacother; 2011 Mar; 12(4):635-40. PubMed ID: 21294670 [TBL] [Abstract][Full Text] [Related]
10. Aripiprazole monotherapy in children and young adolescents with pervasive developmental disorders: a retrospective study. Masi G; Cosenza A; Millepiedi S; Muratori F; Pari C; Salvadori F CNS Drugs; 2009; 23(6):511-21. PubMed ID: 19480469 [TBL] [Abstract][Full Text] [Related]
11. Aripiprazole in the treatment of challenging behaviour in adults with autism spectrum disorder. Jordan I; Robertson D; Catani M; Craig M; Murphy D Psychopharmacology (Berl); 2012 Oct; 223(3):357-60. PubMed ID: 22535309 [TBL] [Abstract][Full Text] [Related]
12. Effectiveness and tolerability of switching to aripiprazole from risperidone in subjects with autism spectrum disorders: a prospective open-label study. Ishitobi M; Kosaka H; Takahashi T; Yatuga C; Asano M; Tanaka Y; Ueno K; Okazaki R; Omori M; Hiratani M; Tomoda A; Wada Y Clin Neuropharmacol; 2013; 36(5):151-6. PubMed ID: 24045605 [TBL] [Abstract][Full Text] [Related]
13. The effectiveness of aripiprazole in the management of problem behaviour in people with intellectual disabilities, developmental disabilities and/or autistic spectrum disorder--a systematic review. Deb S; Farmah BK; Arshad E; Deb T; Roy M; Unwin GL Res Dev Disabil; 2014 Mar; 35(3):711-25. PubMed ID: 24405794 [TBL] [Abstract][Full Text] [Related]
14. Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder. Owen R; Sikich L; Marcus RN; Corey-Lisle P; Manos G; McQuade RD; Carson WH; Findling RL Pediatrics; 2009 Dec; 124(6):1533-40. PubMed ID: 19948625 [TBL] [Abstract][Full Text] [Related]
15. A retrospective review of the effectiveness of aripiprazole in the treatment of sensory abnormalities in autism. Fung LK; Chahal L; Libove RA; Bivas R; Hardan AY J Child Adolesc Psychopharmacol; 2012 Jun; 22(3):245-8. PubMed ID: 22537360 [TBL] [Abstract][Full Text] [Related]
16. The effects of aripiprazole on electrocardiography in children with pervasive developmental disorders. Ho JG; Caldwell RL; McDougle CJ; Orsagh-Yentis DK; Erickson CA; Posey DJ; Stigler KA J Child Adolesc Psychopharmacol; 2012 Aug; 22(4):277-83. PubMed ID: 22849533 [TBL] [Abstract][Full Text] [Related]
17. Line-item analysis of the Aberrant Behavior Checklist: results from two studies of aripiprazole in the treatment of irritability associated with autistic disorder. Aman MG; Kasper W; Manos G; Mathew S; Marcus R; Owen R; Mankoski R J Child Adolesc Psychopharmacol; 2010 Oct; 20(5):415-22. PubMed ID: 20973712 [TBL] [Abstract][Full Text] [Related]
18. Clinical effects and adverse reactions of off-label use of aripiprazole in children and adolescents with developmental disabilities. Valicenti-McDermott MR; Demb H J Child Adolesc Psychopharmacol; 2006 Oct; 16(5):549-60. PubMed ID: 17069544 [TBL] [Abstract][Full Text] [Related]